Delphinus Medical Technologies

Delphinus Medical Technologies, LLC develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.

Company Growth (employees)
Novi, US
Size (employees)
58 (est)+4%
Delphinus Medical Technologies was founded in 2010 and is headquartered in Novi, US

Delphinus Medical Technologies Office Locations

Delphinus Medical Technologies has offices in Novi and Sunnyvale
Novi, US (HQ)
45525 Grand River Ave
Sunnyvale, US
100 920 Thompson Pl
Show all (2)

Delphinus Medical Technologies Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$58.5 m

Latest funding size

$39.5 m

Time since last funding

over 2 years


Delphinus Medical Technologies's latest funding round in September 2015 was reported to be $39.5 m. In total, Delphinus Medical Technologies has raised $58.5 m

Delphinus Medical Technologies's Web-traffic and Trends

Delphinus Medical Technologies Company Life and Culture

You may also be interested in